FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105. A total of 4 filers reported holding FOAMIX PHARMACEUTICALS LTD in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $374,000 | +2.7% | 114,087 | -3.7% | 0.01% | 0.0% |
| Q3 2019 | $364,000 | +43.9% | 118,443 | +12.4% | 0.01% | +62.5% |
| Q2 2019 | $253,000 | -15.1% | 105,360 | +32.7% | 0.01% | -46.7% |
| Q1 2019 | $298,000 | +1.4% | 79,411 | -3.1% | 0.02% | +7.1% |
| Q4 2018 | $294,000 | +4.3% | 81,972 | +66.6% | 0.01% | +27.3% |
| Q3 2018 | $282,000 | +76.2% | 49,199 | +53.6% | 0.01% | +10.0% |
| Q1 2018 | $160,000 | -3.6% | 32,021 | +19.9% | 0.01% | -16.7% |
| Q4 2017 | $166,000 | +33.9% | 26,706 | +19.5% | 0.01% | +9.1% |
| Q3 2017 | $124,000 | +27.8% | 22,340 | +6.8% | 0.01% | +37.5% |
| Q2 2017 | $97,000 | – | 20,927 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DSC Advisors, L.P. | 1,667,377 | $15,440,000 | 9.38% |
| GREAT POINT PARTNERS LLC | 2,769,425 | $25,645,000 | 6.54% |
| Opaleye Management Inc. | 630,000 | $5,834,000 | 3.05% |
| Vivo Capital, LLC | 855,000 | $7,917,000 | 2.47% |
| DAFNA Capital Management LLC | 278,067 | $2,575,000 | 1.79% |
| RA Capital Management | 1,820,138 | $16,854,000 | 1.74% |
| SENZAR ASSET MANAGEMENT, LLC | 523,397 | $4,846,656,000 | 1.25% |
| Perceptive Advisors | 1,373,284 | $12,717,000 | 0.82% |
| Monashee Investment Management LLC | 225,000 | $2,084,000 | 0.73% |
| NEXTHERA CAPITAL LP | 125,000 | $1,158,000 | 0.71% |